Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2002 | 06-2002 | 04-2002 | 03-2002 | 01-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -400 | -3,480 | N/A | -1,520 | -1,520 |
| Depreciation Amortization | 30 | 110 | N/A | 80 | 80 |
| Accounts receivable | 0 | N/A | -6 | N/A | 0 |
| Other Working Capital | 30 | -60 | N/A | -50 | -50 |
| Other Operating Activity | 20 | 1,540 | 6 | 0 | 0 |
| Operating Cash Flow | $-320 | $-1,890 | $N/A | $-1,490 | $-1,490 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -370 | N/A | -220 | -220 |
| Other Investing Activity | -10 | 0 | 0 | -40 | -40 |
| Investing Cash Flow | $-30 | $-370 | $N/A | $-260 | $-260 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 190 | N/A | 0 |
| Common Stock Issued | 0 | N/A | 537 | N/A | 0 |
| Other Financing Activity | -50 | 460 | -727 | 410 | 410 |
| Financing Cash Flow | $-50 | $460 | $N/A | $410 | $410 |
| Beginning Cash Position | 2,440 | 4,250 | N/A | 4,250 | 4,250 |
| End Cash Position | 2,020 | 2,440 | N/A | 2,900 | 2,900 |
| Net Cash Flow | $-420 | $-1,800 | $N/A | $-1,340 | $-1,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -320 | -1,890 | N/A | -1,490 | -1,490 |
| Capital Expenditure | 0 | N/A | -377 | N/A | 0 |
| Free Cash Flow | -320 | -1,890 | -377 | -1,490 | -1,490 |